Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.31 (
beta-glucuronidase
)
7,680
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Correlations were sought between local cerebral metabolic rates (LCMRs) for glucose in various regions of the cortex, determined in premortem PET scans, with the regional activities of choline acetyltransferase (ChAT), acetylcholinesterase (AChE),
beta-glucuronidase
(Gluc, a probable index of reactive gliosis), and phosphate-activated glutaminase (PAG, a possible indice of the large pyramidal neurons) measured on postmortem tissue. Significant negative correlations between LCMRs and Gluc activities were found in 6 PET-scanned cases of Alzheimer disease (AD), and positive correlations of LCMRs with PAG were found in 5. By contrast, a positive correlation with ChAT and AChE was found in only 1. The results are consistent with the metabolic deficits in AD being primarily a reflection of local neuronal loss and gliosis. Similar data on two cases of
Huntington's disease
showed no significant correlations, while 1 patient with Parkinson dementia showed a significant (negative) correlation only with Gluc.
...
PMID:Correlations of regional postmortem enzyme activities with premortem local glucose metabolic rates in Alzheimer's disease. 207 21
Enzymes considered to be markers for neurons (angiotensin converting enzyme, thermolysin-like metalloendopeptidase, alanine aminopeptidase, and glutamate-oxaloacetate transaminase), glia (glutamine synthetase, pyruvate carboxylase, and
beta-glucuronidase
), and endothelial cells (alkaline phosphatase and plasminogen activator) were measured in caudate nucleus from 10 sudden death controls, eight agonal state controls, and 16
Huntington's disease
patients. Glutamate-oxaloacetate transaminase was slightly reduced by agonal state. The four enzymes with a neuronal distribution were all correlatively reduced in
Huntington's disease
caudate nucleus. Glutamine synthetase activity was reduced and
beta-glucuronidase
mean activity increased over twofold in
Huntington's disease
caudate nucleus, with the two enzyme activities being inversely related. Pyruvate carboxylase was markedly affected by agonal state and was very variable in
Huntington's disease
caudate nucleus. The two endothelial enzymes were unaltered in
Huntington's disease
caudate nucleus. The findings are indicative of neuronal loss, an increased proportion of altered glia, and also of maintained vasculature in
Huntington's disease
caudate nucleus. Measurement of enzyme activities can help to delineate the types of cell altered in
Huntington's disease
.
...
PMID:Changes in nine enzyme markers for neurons, glia, and endothelial cells in agonal state and Huntington's disease caudate nucleus. 287 90
Activities of enzyme markers of subcellular organelles have been measured in brain tissue from subjects with Alzheimer-type dementia (ATD) and
Huntington's disease
(HD). Significant increases in the activity of the lysosomal enzyme
beta-glucuronidase
were observed in both ATD temporal cortex and HD putamen. It is suggested that
beta-glucuronidase
activity may be a useful biochemical indicator of cellular damage in the CNS. A significant reduction in neutral alpha-glucosidase activity was observed in ATD temporal cortex and HD putamen. This change may reflect an alteration in glycoconjugate processing and may relate to the susceptibility of neurones to the degenerative processes of ATD and HD.
...
PMID:Subcellular pathology of human neurodegenerative disorders: Alzheimer-type dementia and Huntington's disease. 294 42